MedPath
HSA Approval

ARCATUS® Triamcinolone acetonide suspension for injection 40 mg/mL

SIN17090P

ARCATUS® Triamcinolone acetonide suspension for injection 40 mg/mL

ARCATUS® Triamcinolone acetonide suspension for injection 40 mg/mL

September 19, 2024

ARCTIC VISION SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantARCTIC VISION SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SUSPENSION

OPHTHALMIC

Medical Information

S01BA05

Manufacturer Information

ARCTIC VISION SINGAPORE PTE. LTD.

Alcami Carolinas Corporation

Active Ingredients

Triamcinolone acetonide

40MG/ML

Triamcinolone

Documents

Package Inserts

Arcatus Triamcinolone acetonide suspension for Injection PI.pdf

Approved: September 19, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARCATUS® Triamcinolone acetonide suspension for injection 40 mg/mL - HSA Approval | MedPath